Generic Drug Pathway Curriculum: From ANDA Submission to Global Reliance

Estimated Value: $150,000
Archived MarylandEducation & Trainingrfi
This bid is closed — responses were due July 28, 2026. It is no longer accepting submissions. We keep closed bids on BidsNexus for reference: agencies often re-issue the same need, and past bids show what they buy and when.
See open bids like this one ↓ · Browse open bids in Maryland →
Jul 17, 2026
Jul 28, 2026 4:00 PM
Education & Training
rfi
61143
AI Summary
This is a Request for Information (RFI) from the FDA's Office of Acquisitions and Grants Services (OAGS) to conduct market research for Global Abbreviated New Drug Application (ANDA) Training Program services. The bid is for curriculum development related to generic drug pathways, from ANDA submission to global reliance. This is not a solicitation for proposals, but rather an information-gathering exercise.
Line Items
ItemQtyUnitEst. Unit PriceEst. TotalCategory
Global Abbreviated New Drug Application (ANDA) Training Program services 1 lot $150,000.00 $150,000.00 Professional Services
Estimated Bid Value$150,000.00

Want the full details?

Sign up free to see the agency name and the original bid posting link. Pro adds the 3 documents, contracting-officer contacts and AI response outlines.

📎 Draft_Global_ANDA_Training_Generic_Drug_Curriculum_Final.docx View
📎 Draft_SOW_Global_ANDA_Training_Program_OC-2026-135574.docx View
📎 Sources_Sought_Vendor_Feedback_Form_OC-2026-135574.docx View
Sign Up Free → Already have an account? Log in

Browse More Bids

Bids in MarylandEducation & Training BidsRFI BidsClosing Soon All Bids